|
15 febrer 2020 |
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo, Ángel
; Porta Balanyà, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza, S.
; Menéndez Menéndez, Javier Abel
|
|
3 març 2016 |
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete Abajo, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo i Font, Àngel Xavier
; Porta Balanyà, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza, S.
; Menéndez Menéndez, Javier Abel
|
|
|
12 setembre 2016 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
2012 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
|
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
|
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
